EUROGENETICS NV has a total of 14 patent applications. Its first patent ever was published in 1993. It filed its patents most often in EPO (European Patent Office), Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are IMMUNETECH INC, MIKROGEN GMBH and EXPRESSION PATHOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Australia | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Netherlands | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Demaurex Marc-Olivier | 9 |
#2 | Spring Jean-Francois | 9 |
#3 | Thomas Hubert | 9 |
#4 | Smets Edgard | 9 |
#5 | Hendriks Dirk | 3 |
#6 | Bosmans Eugene | 3 |
#7 | Scharpe Simon | 3 |
#8 | Kestens Luc | 3 |
#9 | Verhelst Peggy | 3 |
#10 | Borloo Marianne | 3 |
Publication | Filing date | Title |
---|---|---|
NL9400309A | Ligand which is able to bind to the adenosine deaminase binding site of CD26 | |
EP0671979A1 | Automated device for performing immunological tests |